Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Patterson

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Vaccine|March 9, 2011
Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremiaEgidio Brocca-Cofano, Katherine McKinnon, Thorsten Demberg, et al.
Journal of Virology|May 7, 2010
Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaquesPeng Xiao, Jun Zhao, L Jean Patterson, et al.
Vaccine|June 29, 2011
Strong viremia control in vaccinated macaques does not prevent gradual Th17 cell loss from central memoryThorsten Demberg, Amelia C Ettinger, Stanley Aladi, et al.
Vaccine|December 15, 2010
Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigsXiaohong Jiang, Tim J Dalebout, Peter J Bredenbeek, et al.
Clinical and Vaccine Immunology : CVI|March 24, 2012
Replicating adenovirus-simian immunodeficiency virus (SIV) vectors efficiently prime SIV-specific systemic and mucosal immune responses by targeting myeloid dendritic cells and persisting in rectal macrophages, regardless of immunization routeL Jean Patterson, Seraphin Kuate, Mara Daltabuit-Test, et al.
Journal of Virology|October 29, 2005
A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia virusesIgor S Lukashevich, Jean Patterson, Ricardo Carrion, et al.
The Journal of Infectious Diseases|July 25, 2022
Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic PreparednessM Cristina Cassetti, Theodore C Pierson, L Jean Patterson, et al.
Journal of Virology|February 14, 2004
Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boostingL Jean Patterson, Nina Malkevitch, David Venzon, et al.
Journal of Virology|August 30, 2008
Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challengeThorsten Demberg, Jean D Boyer, Nina Malkevich, et al.
Journal of Virology|July 30, 2003
Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120L Jean Patterson, Nina Malkevitch, Joel Pinczewski, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Vaccine|March 9, 2011
Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremiaEgidio Brocca-Cofano, Katherine McKinnon, Thorsten Demberg, et al.
Journal of Virology|May 7, 2010
Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaquesPeng Xiao, Jun Zhao, L Jean Patterson, et al.
Vaccine|June 29, 2011
Strong viremia control in vaccinated macaques does not prevent gradual Th17 cell loss from central memoryThorsten Demberg, Amelia C Ettinger, Stanley Aladi, et al.
Vaccine|December 15, 2010
Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigsXiaohong Jiang, Tim J Dalebout, Peter J Bredenbeek, et al.
Clinical and Vaccine Immunology : CVI|March 24, 2012
Replicating adenovirus-simian immunodeficiency virus (SIV) vectors efficiently prime SIV-specific systemic and mucosal immune responses by targeting myeloid dendritic cells and persisting in rectal macrophages, regardless of immunization routeL Jean Patterson, Seraphin Kuate, Mara Daltabuit-Test, et al.
Journal of Virology|October 29, 2005
A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia virusesIgor S Lukashevich, Jean Patterson, Ricardo Carrion, et al.
The Journal of Infectious Diseases|July 25, 2022
Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic PreparednessM Cristina Cassetti, Theodore C Pierson, L Jean Patterson, et al.
Journal of Virology|February 14, 2004
Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boostingL Jean Patterson, Nina Malkevitch, David Venzon, et al.
Journal of Virology|August 30, 2008
Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challengeThorsten Demberg, Jean D Boyer, Nina Malkevich, et al.
Journal of Virology|July 30, 2003
Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120L Jean Patterson, Nina Malkevitch, Joel Pinczewski, et al.
Pageof 5